American Century Companies’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-269,602
Closed -$23.9M 2956
2025
Q1
$23.9M Buy
+269,602
New +$23.4M 0.01% 964
2024
Q4
Sell
-21,759
Closed -$923K 2959
2024
Q3
$923K Buy
21,759
+4,501
+26% +$152K ﹤0.01% 2270
2024
Q2
$451K Buy
17,258
+4,573
+36% +$86.7K ﹤0.01% 2481
2024
Q1
$116K Buy
+12,685
New +$76.1K ﹤0.01% 2847

Other funds holding WGS

American Century Companies's WGS Position: Q2 2025 in Review

American Century Companies sold out of GeneDx Holdings (WGS) in Q2 2025, closing a stake of 269,602 shares — an estimated $23.9M sold.

American Century Companies first reported a position in WGS in Q1 2024 and held it in 4 quarters. The position peaked at $23.9M in Q1 2025. 231 funds tracked by Wall St. Rank hold WGS as of Q2 2025.

  • American Century Companies reported no remaining GeneDx Holdings position as of Q2 2025 after selling out during the quarter.
  • American Century Companies sold 269,602 GeneDx Holdings shares in Q2 2025, an estimated $23.9M.
  • American Century Companies first reported a position in GeneDx Holdings in Q1 2024 and held it in 4 quarters.
  • American Century Companies's GeneDx Holdings position peaked at $23.9M in Q1 2025.
  • 231 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2025.

Based on American Century Companies's 13F filing for Q2 2025, filed 12 Aug 2025.